↓ Skip to main content

Increased expression of podoplanin in malignant astrocytic tumors as a novel molecular marker of malignant progression

Overview of attention for article published in Acta Neuropathologica, April 2006
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (85th percentile)
  • High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

patent
5 patents
wikipedia
1 Wikipedia page

Citations

dimensions_citation
208 Dimensions

Readers on

mendeley
59 Mendeley
Title
Increased expression of podoplanin in malignant astrocytic tumors as a novel molecular marker of malignant progression
Published in
Acta Neuropathologica, April 2006
DOI 10.1007/s00401-006-0063-y
Pubmed ID
Authors

Kazuhiko Mishima, Yukinari Kato, Mika Kato Kaneko, Ryo Nishikawa, Takanori Hirose, Masao Matsutani

Abstract

Podoplanin (aggrus) is a mucin-like transmembrane sialoglycoprotein that is expressed on lymphatic endothelial cells. Podoplanin is putatively involved in cancer cell migration, invasion, metastasis, and malignant progression and may be involved in platelet aggregation. Previously, we showed upregulated expression of podoplanin in central nervous system (CNS) germinomas, but not in non-germinomatous germ cell tumors, except for parts of immature teratomas in limited numbers. However, little information exists about its role in CNS astrocytic tumors. In this study, 188 astrocytic tumors (30 diffuse astrocytomas, 43 anaplastic astrocytomas, and 115 glioblastomas) were investigated using immunohistochemistry with an anti-podoplanin antibody, YM-1. In 11 of 43 anaplastic astrocytomas (25.6%) and in 54 of 115 glioblastomas (47.0%), podoplanin was expressed on the surface of anaplastic astrocytoma cells and glioblastoma cells, especially around necrotic areas and proliferating endothelial cells. However, the surrounding brain parenchyma was not stained by YM-1. On the other hand, podoplanin expression was not observed in diffuse astrocytoma (0/30: 0%). Furthermore, we investigated the expression of podoplanin using quantitative real-time PCR and Western blot analysis in 54 frozen astrocytic tumors (6 diffuse astrocytomas, 14 anaplastic astrocytomas, and 34 glioblastomas). Podoplanin mRNA and protein expression were markedly higher in glioblastomas than in anaplastic astrocytomas. These data suggest that podoplanin expression might be associated with malignancy of astrocytic tumors.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 59 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Australia 1 2%
Unknown 58 98%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 15 25%
Student > Bachelor 7 12%
Student > Doctoral Student 7 12%
Student > Master 5 8%
Researcher 4 7%
Other 10 17%
Unknown 11 19%
Readers by discipline Count As %
Medicine and Dentistry 18 31%
Biochemistry, Genetics and Molecular Biology 10 17%
Agricultural and Biological Sciences 10 17%
Nursing and Health Professions 2 3%
Veterinary Science and Veterinary Medicine 2 3%
Other 3 5%
Unknown 14 24%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 December 2022.
All research outputs
#3,380,475
of 23,377,816 outputs
Outputs from Acta Neuropathologica
#869
of 2,395 outputs
Outputs of similar age
#7,325
of 67,200 outputs
Outputs of similar age from Acta Neuropathologica
#1
of 13 outputs
Altmetric has tracked 23,377,816 research outputs across all sources so far. Compared to these this one has done well and is in the 84th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,395 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 14.6. This one has gotten more attention than average, scoring higher than 62% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 67,200 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 85% of its contemporaries.
We're also able to compare this research output to 13 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 92% of its contemporaries.